Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
05/2010
05/27/2010US20100130495 Compounds 563
05/27/2010US20100130448 3',4',5-trimethoxy flavone derivatives as stimulatn of mucus secretion, method for the same, and pharmaceutical composition comprising the same
05/27/2010US20100130446 Nitrogen-containing five-membered heterocyclic compound
05/27/2010US20100127213 Liquid crystalline medium and liquid crystal display
05/27/2010US20100127212 Pyridine compounds for liquid-crystalline mixtures
05/27/2010CA2744351A1 New compounds
05/27/2010CA2741986A1 Method and apparatus for manure treatment
05/26/2010EP2189458A1 Aryl amide compound as an acetyl coenzyme A carboxylase inhibitor
05/26/2010EP2189449A1 Aminopyrazole amide derivative
05/26/2010EP2188280A2 Imidazopyridinones
05/26/2010EP2188263A1 Benzimidazole derivatives used as fxr agonists
05/26/2010EP2188258A1 Substituted nicotinamide compounds and the use thereof in pharmaceutical products
05/26/2010EP1874739B1 Pharmaceutically active diazepanes
05/26/2010EP1651639B1 Benzofuran derivatives and their use in the treatment of microbial infections
05/26/2010EP1651613B1 4,5-dihydro-imidazole as p2x7 ion channel blockers
05/26/2010EP1585727B1 Indoles useful in the treatment of androgen-receptor related diseases
05/26/2010EP1315709B1 Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
05/26/2010EP1303495B1 Substituted 5-alkynyl pyrimidines having neurotrophic activity
05/26/2010CN1949966B Quinoxalin-2-one derivatives, crop protection agents comprising the same and method for production and use therof
05/26/2010CN1856478B Bicyclic imino acid derivatives as inhibitors of matrix metalloproteinases
05/26/2010CN1849117B Entry inhibitors of the HIV virus
05/26/2010CN1746168B Optically active doxazosin
05/26/2010CN1720245B Oxime ester photoinitiators with heteroaromatic groups
05/26/2010CN1642920B 5-substituted-alkylaminopyrazole derivatives as pesticides
05/26/2010CN1642580B Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
05/26/2010CN1553814B Remedies for arteriosclerosis
05/26/2010CN1549716B 3-substituted 6,7-dihydroxytetrahydroisoquinoline derivatives for use as antibacterial agents
05/26/2010CN1489580B 咪唑衍生物 Imidazole derivatives
05/26/2010CN101712867A Organic electronic transmission and/or hole barrier materials, synthetic method and applications thereof
05/26/2010CN101712657A heteroarylcarbamoylbenzene derivative
05/26/2010CN101712655A Acetamide derivative and application thereof in pharmacy
05/26/2010CN101712647A Metal complex for optical recording material and preparation method as well as prepared optical recording dye thereof
05/25/2010US7723375 Metabolites of wortmannin analogs and methods of using the same
05/25/2010US7723374 3-[5-ethoxy-1-(4-ethyl-benzenesulfonyl)-1H-indol-3-yl]-propionic acid for example; obesity, diabetes, syndrome X, breast or thyroid cancer, inflammatory skin disorders such as psoriasis, cardiovascular disorders, eating disorders such as bulimia; peroxisome proliferator-activated receptors (PPAR) agonist
05/25/2010US7723372 Spiro[2-cyclohexene-1,3'-[3H]indole]-2',4(1'H)-diones and 4-hydroxyspiro[2-cyclohexene-1,3'-[3H]indol]-2'(1'H)-ones; act as antagonists of mdm2 interactions; useful as potent and selective anticancer agents
05/25/2010US7723367 Amino-tetrazoles analogues and methods of use
05/25/2010US7723361 Kaposi's sarcoma; Crohn's disease; combination therapy with an epoxide hydrolase inhibitor
05/25/2010US7723358 such as hypertriglyceridaemia, hypercholesterolemia, dyslipidaemia, or obesity; 6-methyl-N-[3-[[1-(methylsulfonyl)-4-piperidinyl]oxy]phenyl]-4'-(trifluoro-methoxy) [1,1'-biphenyl]-2-carboxamide
05/25/2010US7723344 Dipeptidyl peptidase inhibitors
05/25/2010US7723321 such as 4-[(5,7-difluoro-3,4-dihydro-2H-chromen-4-yl)oxyl]-N,N,2-trimethyl-1H-benzimidazole -6-carboxamide, used as acid pump antagonists for the treatment of gastrointestinal disorders
05/25/2010CA2496723C New process for synthesizing ivrabradine and its pharmaceutically acceptable acid addition salts
05/25/2010CA2489337C Indole derivatives useful as histamine h3 antagonists
05/25/2010CA2489136C Novel 3-(4-oxo-40-chromen-2-yl)-(1h)-quinoline-4-one derivatives, method for preparing same and pharmaceutical compositions containing same
05/25/2010CA2471529C Colorant compounds
05/25/2010CA2273917C 3-pyridyl enantiomers and their use as analgesics
05/25/2010CA2248303C Perfluorinated amide salts and their uses as ionic conducting materials
05/20/2010WO2010056875A1 Pyridazinones and their use as btk inhibitors
05/20/2010WO2010056549A1 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators
05/20/2010WO2010055164A2 Novel inhibitors of flavivirus replication
05/20/2010WO2010055117A1 2,4-diaminopyrimidine derivates as ptk2- inhibitors for the treatment of abnormal cell growth
05/20/2010WO2010055083A1 Novel pyrazolone-derivatives and their use as pd4 inhibitors
05/20/2010WO2010055077A1 Substituted (pyridyl)-azinylamine derivatives as fungicides
05/20/2010WO2010054968A1 Quinazoline derivatives as nk3 receptor antagonists
05/20/2010WO2010054954A1 Process for manufacturing 5-chloromethyl-2,3-pyridine dicarboxylic acid anhydrides
05/20/2010WO2010054575A1 Acenaphtho heterocycle compounds, cyclodextrin inclusion compounds and complexes, and uses in the manufactures of bh3 protein analogue, bcl-2 family protein inhibitors thereof
05/20/2010WO2010054528A1 Quinazoline compounds
05/20/2010WO2010036631A3 Sulfonyl compounds which selectively modulate the cb2 receptor
05/20/2010WO2010036630A3 Sulfonyl compounds which selectively modulate the cb2 receptor
05/20/2010WO2010027567A3 Tricyclic spirocycle derivatives and methods of use thereof
05/20/2010US20100125139 Process for preparing quinazoline rho-kinase inhibitors and intermediates thereof
05/20/2010US20100125079 Biphenyl compounds useful as muscarinic receptor antagonists
05/20/2010US20100125075 Antibacterial Agents
05/20/2010US20100125073 Benzofuran and benzothiophene derivatives useful in the treatment of cancers of the central nervous system
05/20/2010US20100125071 Cxc-chemokine receptor ligands
05/20/2010US20100124543 Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors
05/20/2010CA2743073A1 2,4-diaminopyrimidine derivates as ptk2- inhibitors for the treatment of abnormal cell growth
05/20/2010CA2742922A1 Novel pyrazolone-derivatives and their use as pd4 inhibitors
05/20/2010CA2742856A1 Acenaphtho heterocycle compounds, cyclodextrin inclusion compounds and complexes, and uses in the manufactures of bh3 protein analogue, bcl-2 family protein inhibitors thereof
05/20/2010CA2742297A1 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators
05/20/2010CA2738787A1 Substituted (pyridyl)-azinylamine derivatives as fungicides
05/20/2010CA2737587A1 Quinazoline derivatives as nk3 receptor antagonists
05/19/2010EP2186897A1 An improved method for synthesising templated molecules
05/19/2010EP2186516A1 Novel benzazepine derivative
05/19/2010EP2185713A2 Process for preparing chiral compounds
05/19/2010EP2185548A1 Fungicide 2-pyridyl-methylene-thio carboxamide or 2-pyridyl-methylene-n-substituted carboximidamide derivatives
05/19/2010EP2185539A1 Viral polymerase inhibitors
05/19/2010EP2185537A1 Pyrimidine and pyridine derivatives and their pharmaceutical use and compositions
05/19/2010EP2185526A2 Fungicide n-cycloalkyl-n-bicyclic-carboxamide derivatives
05/19/2010EP2185512A2 Trans-3-aza-bicyclo[3.1.0]hexane derivatives
05/19/2010EP2185507A1 Fungicide n-6-membered fused (hetero)aryl-methylene-n-cycloalkyl carboxamide derivatives
05/19/2010EP2185506A1 Pyrrole compounds having sphingosine-1-phosphate receptor agonist or antagonist biological activity
05/19/2010EP2184987A1 Bi-dentate compounds as kinase inhibitors
05/19/2010EP1599467B1 Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders
05/19/2010EP1558246B1 Proline derivatives having affinity for the calcium channel alpha-2-delta subunit
05/19/2010EP1330454B1 Benzopyranyl heterocycle derivatives, process for preparation thereof, and pharmaceutical compositions containing them
05/19/2010CN101711245A 5-membered heterocyclic amides and related compounds
05/19/2010CN101711244A 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
05/19/2010CN101711243A 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives
05/19/2010CN101711242A ((Bicylicheteroaryl) imidazolyl) methylheteroaryl compounds as adrenergic receptor agonists
05/19/2010CN101711241A PI 3-kinase inhibitors and methods of their use
05/18/2010US7718818 zirconium complexes of bis(o-hydroxybenzylamines); useful as intermediates for the preparation of fine chemicals, pharmaceuticals and plant protection products such as arthropodicidal oxadiazines
05/18/2010US7718809 Such as 4-[(7-fluoro-3,4-dihydro-2H-chromen-4yl)oxy]-N,N,1,2-tetramethyl-1H-benzimidazole-6-carboxamide; gastrointestinal and airway disorders; metabolically stable, pharmacokinetics, nontoxic; nonhygroscopic, easily formulated
05/18/2010US7718706 pesticides and/or herbicides for controlling pests in crop protection, in the domestic sector, in the hygiene sector and in the protection of stored products
05/18/2010US7718704 Immunosuppressant compounds and compositions
05/18/2010US7718686 Gastrointestinal disorders; irritable bowel syndrome
05/18/2010US7718673 Heterocyclic amides such as beta-(((1-(4-((4,5-dihydro-1H-imidazol-2-yl)amino)-1-oxobutyl)-4 -piperidinyl)carbonyl)amino) -,(beta 3S)-3-quinolinepropanoic acid, used as antagonists for cellular adhesion molecules
05/18/2010US7718655 formed via cyanuric chloride; for treatment of cancer and proliferative diseases
05/18/2010US7718651 Inhibiting polymerization of FtsZ in a bacterium by contactng with 2,3-diphenyl-6-(ethoxycarbonylamino)-8-(4-(diethylamino)-1-methylbutylamino)pyrido[2,3-b]pyrazine, optionally linked to a permeability enhancer to allow the compound to cross the bacterium's cell envelope
05/18/2010CA2465247C Benzimidazoles and analogues and their use as protein kinases inhibitors
05/18/2010CA2422371C Pyrazole compounds useful as protein kinase inhibitors
1 ... 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 ... 694